Multi-Centre, Observational Study on Safety of Bevacizumab Biosimilars in Clinical Practice Among Chinese Patients

计划入组 272 人 · 首次发布于 2021 年 8 月 17 日

Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer

计划入组 62 人 · 首次发布于 2022 年 4 月 26 日

Lurbinectedin Combined With Durvalumab in Pre-treated Patients With Extensive Stage Small-cell Lung Cancer

首次发布于 2022 年 10 月 7 日

Madalena association

Canada Association

Saturno IIB Association

Biosimilar Collaborations Ireland Ltd.

Ireland

Alzheimer's Disease And Related Disorders Association, Inc.

United States

GENERIC DEVICES CONSULTING, INC.

United States

GBMA Intervenes in Landmark Australian High Court Case on Pharmaceutical Patent Term Extensions

Samsung Bioepis and Organon Expand Australian Biosimilar Partnership to Four Products as PBS Default Reform Looms

Patent Settlements Accelerate Generic and Biosimilar Market Entry, Generating $423 Billion in Healthcare Savings